TLRY heads into Thursday's earnings release with options traders the most defensive they have been in months, even as short positioning remains modest relative to the stock's troubled history.
The sharpest pre-earnings signal comes from options. The put/call ratio jumped to 0.28 on Monday — nearly three standard deviations above its 20-day average of 0.19, the most elevated defensive reading in the recent period. That is a notable shift for a stock where call activity has consistently dominated. The context matters: TLRY has dropped 10.6% over the past month to $4.23, erasing a brief mid-week recovery, and the stock now sits near the lower end of its 52-week range. Options traders appear to be hedging into the release rather than positioning for a bounce.
The lending market adds texture without changing the story's direction. Availability has tightened to roughly 18% — meaning only about one share remains available for every five already on loan — though this is actually a loosening from the extreme squeeze seen in mid-June, when availability briefly fell to near zero. Cost to borrow has drifted down roughly 16% over the past month to around 7.9%, suggesting the most acute borrow pressure has passed. Short interest at 1.6% of the free float is low enough that there is no meaningful squeeze dynamic at play heading into the print.
The analyst picture is one of creeping disappointment. TD Cowen trimmed its target to $5 from $7 last week — the second cut from that desk in four months — while maintaining a Buy rating. The consensus mean target sits at $9.30, more than double the current price, but the gap between that target and where the stock actually trades speaks to years of execution frustration rather than genuine near-term optimism. Roth Capital upgraded to Buy in April at a $10 target. Bears point to persistent quality weakness — the F-score is a low 3, return metrics are negative, and momentum across every time frame is negative. Bulls lean on a price-to-book of roughly 0.52 and EV/EBITDA near 5.9x, arguing the stock is priced for failure. Cannabis sector peers were mixed on the day: Canopy Growth WEED gained 2.3% while SNDL and Aurora Cannabis ACB were little changed on the week, leaving TLRY's slide a somewhat idiosyncratic move.
ORTEX's short score has held steady near 74 for the past two weeks — near the high end of the range — reflecting tight availability and elevated borrow cost rather than a surge in new short positions. Thursday's report will test whether the company's beverage alcohol pivot is generating enough revenue momentum to justify any re-rating, or whether the gap between analyst targets and market reality continues to widen.
See the live data behind this article on ORTEX.
Open TLRY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
